Medtronic plc — Director's Dealing 2025

Jul 30, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2025-07-28

Reporting Person: Pieton Thierry (EVP & Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-07-28	Ordinary Shares	A	8699	—	Acquired	39958	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-07-28	Performance Share Units	$	A	21747	Acquired		Performance Share Unit (21747)	Direct
2025-07-28	Stock Option (Right to Buy)	$91.97	A	61338	Acquired	2035-07-28	Ordinary Shares (61338)	Direct

Footnotes

F1: Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

F2: Includes 505 shares acquired through dividend reinvestment since the last report filed by the reporting person.

F3: Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

F4: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028.

F5: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 21,747 shares will be issued. If maximum performance metrics are achieved, 43,494 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

F6: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.